OS Therapies Incorporated
OSTX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $89 | $50 | $58 | $58 |
| - Cash | $6 | $0 | $0 | $0 |
| + Debt | $6 | $15 | $10 | $7 |
| Enterprise Value | $90 | $65 | $68 | $65 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$7 | -$4 | -$4 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$9 | -$8 | -$6 | -$7 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.52 | -0.39 | -0.28 | -0.33 |
| % Growth | -33.3% | -39.3% | 15.2% | – |
| Operating Cash Flow | -$7 | -$3 | -$4 | -$4 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$7 | -$3 | -$4 | -$4 |